Eleanor G. Rogan

Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators

Ercole L. Cavalieri, Douglas E. Stack, Prabhakar D. Devanesan et al. · Proceedings of the National Academy of Sciences · 1997 · 730 citations

Medicine, Molecular Biology, Oncology +17

Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis.

Howard F. Tiano, Charles D. Loftin, Jackie Akunda et al. · PubMed · 2002 · 345 citations

Medicine, Dermatology, Cancer Pharmacology +7

IDH2 R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma

Chao Wang, Timothy W. McKeithan, Qiang Gong et al. · Blood · 2015 · 248 citations · Full text

Medicine, Hematology, Oncology +13

Comparative dose—response tumorigenicity studies of dibenzo[<i>a,l</i>]pyrene versus 7, 12-dimethylbenz[<i>a</i>]anthracene, benzo[<i>a</i> and two dibenzo[<i>a,l</i>]pyrene dihydrodiols in mouse skin and rat mammary gland

Ercole L. Cavalieri, Sheila Higginbotham, N. V. S. Ramakrishna et al. · Carcinogenesis · 1991 · 246 citations

Pharmacy, Oncology, Toxicology +6

Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases

Ercole L. Cavalieri, Kaiming Li, Narayanan Balu et al. · Carcinogenesis · 2002 · 225 citations

Pharmacy, Biochemistry, Toxicology +15